Healthcare Administration & Management · Independent exam preparation
ISTM Certificate of Knowledge in Travel Medicine: Free CTH Preparation Guide Study Guide
Practise itinerary-based prevention, vaccine safety, malaria choices and returned-traveller triage with 60 focused concepts and 20 explained CTH learning questions.
By CertMedbry · Updated 3 November 2026
Practise choosing prevention for a specific itinerary, recognising vaccine and medication hazards, and identifying returned travellers who need urgent assessment. This guide prepares licensed healthcare professionals for the ISTM Certificate of Knowledge™ in Travel Medicine Examination, whose successful candidates receive the Certificate in Travel Health™ designation, CTH®. Its 60 selected concepts follow the seven weighted domains of the linked 2017 Body of Knowledge. The complete official outline defines the full examination scope, including many additional infections, vaccines, populations and professional responsibilities.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and professional level does this guide address?
It addresses the ISTM Certificate of Knowledge™ in Travel Medicine Examination. Passing leads to the Certificate in Travel Health™ designation, CTH®. The listing label 'Certification in Travel Health' refers to this examination, rather than a separate pathway. ISTM welcomes licensed healthcare professionals providing travel-health services, including physicians, nurses, pharmacists and physician assistants. This is a professional knowledge credential; it does not confer a nursing, medical or prescribing licence or guarantee clinical competence.
How many questions are scored, and how long is the examination?
ISTM specifies 220 multiple-choice questions: 200 scored questions and 20 unscored pilot questions. Each question has four answer choices. The examination takes place in one session lasting 4 hours and 45 minutes and is administered in British English.
Which delivery methods are available, and is the examination adaptive?
ISTM describes remote live proctoring through ProctorU, approved testing centres and onsite administration, with availability varying by examination. The announced 2 May 2027 Bangkok administration is onsite only, in conjunction with CISTM20. ISTM's format information does not establish adaptive testing. These practice questions are independent four-option single-best-answer drills.
Which blueprint applies, and what does its revision date mean?
The currently linked ISTM Body of Knowledge is revised 2017 and is identified as the examination basis in the 2026 candidate information. No separate blueprint effective date is stated. The revision year describes the outline, not the publication date of every clinical recommendation. Candidates should study its complete scope alongside current authoritative clinical guidance.
How are the official domains weighted in this guide?
ISTM gives approximate weights of Epidemiology 10%; Immunology/Vaccinology 20%; Pretravel Assessment/Consultation 35%; Diseases Contracted During Travel 12%; Other Clinical Conditions Associated with Travel 10%; Post-Travel Assessment 8%; and Administrative and General Travel Medicine Issues 5%. The 60 concepts allocate 6, 12, 21, 7, 6, 5 and 3 entries respectively. Both the 20 questions and 20 flashcards allocate 2, 4, 7, 2, 2, 2 and 1 entries respectively, allowing for rounding.
Is there a fixed passing percentage?
ISTM measures performance against a standard of knowledge expected of a practitioner with basic competence in travel medicine, rather than against other candidates. An expert standard-setting process determines the required score for each examination; the FAQ does not give a universal passing percentage. Successful candidates receive a pass notification without a numerical score. Unsuccessful candidates receive their score, the minimum passing score and a content-area diagnostic report.
What experience and continuing development does ISTM describe?
ISTM strongly recommends at least three years of travel-medicine experience and/or formal education or training, although this recommendation is not described as mandatory. The current programme describes a five-year credential and continuing professional development cycle. Applicants and credential holders should use the administration-specific eligibility and renewal instructions applicable to them.
How should international candidates use the clinical recommendations?
The examination addresses international travel-medicine knowledge. CDC guidance supports the clinical examples here, but vaccine products, authorised schedules, prescribing rules and national recommendations can differ. A recommendation intended to protect a traveller and a destination's legal entry requirement answer different questions. Identify the relevant national guidance and itinerary-specific entry rules before applying either in practice.
ISTM Body of Knowledge · CDC Yellow Book: The Pre-Travel Consultation · CDC Yellow Book: Yellow Fever
These independently authored learning materials assess travel-medicine knowledge through clinical decisions and explanations. They are not official ISTM questions or a prediction of examination performance. CDC references support the clinical teaching; ISTM references establish examination scope and format. Product authorisation and national recommendations can differ across jurisdictions.
Outline used: ISTM Body of Knowledge for the Practice of Travel Medicine, revised 2017, remains the outline linked by ISTM and identified as the examination basis in its 2026 candidate brochure. No separate effective date is stated. The assigned label 'Certification in Travel Health (CTH)' maps to this examination, whose successful candidates receive the Certificate in Travel Health™ (CTH®); it is not a separate examination.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Epidemiology10%
1.How is attack risk calculated for a travel group?
Attack risk is the proportion of an initially disease-free, at-risk group that develops disease during a defined interval. Divide new cases by the people at risk at the start, then express the result as a proportion or percentage. The denominator must match the exposure and observation period. This measure describes the probability of becoming a case during that episode, whereas person-time incidence incorporates differing lengths of observation.
Apply it
During a five-day tour, 18 of 90 initially well participants develop diarrhoea. Calculate an attack risk of 20%. Exclude people already ill at departure when defining the population at risk for a new episode.
Common pitfall: Dividing cases by all registered travellers can distort risk if some were already cases or never joined the exposure period being evaluated.
CDC Principles of Epidemiology: Morbidity Frequency Measures
2.Why can confounding distort a prevention comparison?
Confounding occurs when another factor distorts the association between an exposure and an outcome. The factor is associated with the exposure and independently related to disease risk, rather than being an intermediate consequence of the exposure. In travel studies, accommodation, season and rural activities can influence both preventive behaviour and infection risk. Compare otherwise similar groups or use appropriate stratification or adjustment before interpreting an observed association as preventive benefit.
Apply it
Travellers using bed nets have more malaria than those without nets, but net users predominantly stayed in high-transmission rural areas. Compare risk within similar destinations and accommodation categories before concluding that nets increased infection.
Common pitfall: A crude association does not establish causation. Greater baseline exposure among people choosing prevention can obscure benefit or even reverse the apparent direction.
CDC Field Epidemiology Manual: Analyzing and Interpreting Data
3.What does prevalence measure at a clinic survey?
Prevalence is the proportion of a defined population with an existing condition at a specified time or during a specified period. It includes existing cases, rather than only new diagnoses. Prevalence reflects both the occurrence of disease and how long people remain affected. A prolonged illness can therefore have substantial prevalence despite relatively few new cases. Always identify the population and time reference before comparing prevalence estimates.
Apply it
A survey finds persistent gastrointestinal symptoms in 24 of 300 returned volunteers on the assessment date. The point prevalence is 8%; the survey alone does not reveal when those symptoms began or the incidence during travel.
Common pitfall: Calling every proportion an incidence estimate hides whether cases were new. Long symptom duration can raise prevalence without an increase in disease acquisition.
CDC Principles of Epidemiology: Morbidity Frequency Measures
4.When is person-time incidence more informative?
Incidence density divides new cases by the accumulated time people remain at risk. It is useful when travellers have different trip lengths or enter and leave observation at different times. A participant generally stops contributing time at risk when the defined first event occurs or follow-up ends. The resulting rate has time units, such as cases per 1,000 traveller-days, and is not itself a percentage probability.
Apply it
Two new infections occur over 2,500 person-days of observation among expedition members. Report 0.8 infections per 1,000 person-days. Record each person's actual at-risk follow-up instead of assuming that everyone completed the same expedition duration.
Common pitfall: A rate per traveller-day cannot be presented as a trip percentage without additional assumptions about exposure duration and how risk changes over time.
CDC Principles of Epidemiology: Morbidity Frequency Measures
5.Which denominator belongs in case fatality?
Case fatality describes the proportion of people with a specified disease who die from it over the relevant course of illness. The denominator is the disease cases, not all travellers or the general population. It therefore addresses severity among affected people rather than the chance of acquiring infection. Interpretation depends on case ascertainment, follow-up and access to treatment, so comparisons require compatible case definitions and observation periods.
Apply it
An outbreak includes 80 confirmed cases and four deaths attributable to that disease. The case-fatality proportion is 5%. The number of unaffected visitors would be relevant to acquisition risk, but does not belong in this denominator.
Common pitfall: Dividing deaths by all exposed visitors estimates a different quantity. A severe disease can have high case fatality while remaining uncommon among travellers.
CDC Principles of Epidemiology: Mortality Frequency Measures
6.How can subnational disease distribution change Japanese encephalitis prevention?
Disease risk is not uniform within an endemic country. Japanese encephalitis transmission is associated particularly with rural agricultural settings, including rice-growing areas, where mosquito exposure can differ substantially from a city-centre itinerary. Season, evening outdoor activity and unscreened accommodation further modify that geographic risk. CDC does not recommend vaccination for very low-risk itineraries such as short trips restricted to urban areas, but recommends considering it for shorter trips with increased rural exposure.
Apply it
Compare two ten-day visits to the same endemic country: a screened city-centre conference and evening fieldwork near rural rice fields during transmission season. The conference generally does not warrant vaccination; the rural assignment warrants considering it despite identical trip duration.
Common pitfall: A national endemicity label cannot establish equal risk in every district. Conversely, a short stay does not make an intensely exposed rural itinerary equivalent to an urban visit.
CDC Yellow Book: Japanese Encephalitis · ISTM Body of Knowledge
Immunology/Vaccinology20%
7.How should injected live vaccines be spaced?
Injected or intranasal live-virus vaccines can interfere with one another if administered too close together on different days. They should generally be given on the same day or separated by at least 28 days. When the minimum interval is violated, the later dose can be invalid and require repetition. Yellow fever and MMR warrant additional attention because CDC describes possible interference and recommends considering a longer interval when feasible.
Apply it
An adult receives MMR and returns ten days later for varicella vaccination before travel. Schedule varicella at least 28 days after MMR, rather than treating the second visit as an acceptable opportunity for another live vaccine.
Common pitfall: The spacing rule concerns different-day live-virus administration. Applying it to all vaccines unnecessarily delays non-live products and can leave travellers without useful protection.
CDC Yellow Book: Vaccination and Immunoprophylaxis—General Principles · CDC: Timing and Spacing of Immunobiologics
8.Why can immune globulin interfere with MMR?
Antibody-containing preparations can neutralise live vaccine virus before sufficient replication stimulates an active immune response. This interference is particularly relevant to measles-containing and varicella vaccines. The interval before vaccination depends on the antibody preparation and dose. CDC specifies an 11-month interval before measles-containing vaccination after intravenous immune globulin given at 2 g/kg for Kawasaki disease. Identify the preparation, dose, indication and administration date when calculating the vaccination date.
Apply it
A child received intravenous immune globulin, 2 g/kg for Kawasaki disease, on 15 January 2026 and requests an indicated MMR dose before travel in June. Defer MMR until at least 15 December 2026, assuming no subsequent antibody-containing treatment and no other contraindication. Explain that the June travel plan occurs before the recommended interval has elapsed.
Common pitfall: The 11-month interval applies to this specific preparation and dose; it cannot be transferred to other immune globulin regimens or blood products. Passive antibody protection is temporary and does not establish that an MMR dose administered during the interference interval will produce a reliable active response.
9.When is yellow fever vaccine contraindicated by immunosuppression?
Yellow fever vaccine contains live attenuated virus. Impaired immune control can permit harmful vaccine-virus replication. Organ transplantation with ongoing immunosuppressive treatment is a contraindication. Symptomatic HIV infection or severe HIV-related immunosuppression also contraindicates vaccination; in adults, a CD4 count below 200 cells/µL meets the severe-immunosuppression criterion. By comparison, asymptomatic HIV infection with a CD4 count of 200–499 cells/µL is a precaution requiring individual assessment of exposure risk and vaccine risk.
Apply it
An adult kidney-transplant recipient taking tacrolimus and mycophenolate plans travel to a yellow-fever-transmission area. The transplant with ongoing immunosuppressive treatment establishes a contraindication: do not administer yellow fever vaccine. Discuss postponement or an itinerary avoiding transmission areas. If travel proceeds, provide mosquito-avoidance counselling and consider a medical waiver when documentation is required.
Common pitfall: A destination's certificate requirement does not override a contraindication, and a waiver provides no protection against infection or guarantee of entry. Conversely, asymptomatic HIV with moderate immunosuppression is a precaution rather than an automatic contraindication; the distinction changes the vaccination assessment.
10.How does prior rabies vaccination change post-exposure care?
For an immunocompetent person with qualifying prior rabies vaccination, indicated post-exposure prophylaxis consists of wound cleansing and vaccine on days 0 and 3 without rabies immune globulin. A documented recognised three-dose pre-exposure series qualifies. A two-dose pre-exposure series does not establish this status indefinitely: exposure more than three years later without an intervening qualifying titre or booster requires full post-exposure prophylaxis, including rabies immune globulin and vaccine on days 0, 3, 7 and 14 under CDC guidance.
Apply it
An immunocompetent traveller bitten four years after a two-dose pre-exposure series has had no subsequent titre or booster. Clean the wound and arrange full post-exposure prophylaxis including immune globulin. An otherwise comparable traveller with a documented recognised three-dose series receives vaccine on days 0 and 3 without immune globulin.
Common pitfall: Pre-exposure vaccination never removes the need for exposure assessment. Before using abbreviated prophylaxis, establish the earlier regimen, its timing and any required follow-up; immunocompromised patients require a different assessment.
11.What should happen after a vaccine temperature excursion?
A temperature excursion can reduce vaccine potency even when the product appears normal. Identify and label the affected stock, prevent its use, and maintain it under the recommended storage conditions while viability is assessed. Document the temperature range, duration and affected products, and consult the appropriate immunisation programme or manufacturer. The assessment determines whether stock remains usable and whether previously administered doses need review. Immediate disposal can destroy information and usable inventory.
Apply it
A refrigerator alarm shows an overnight temperature outside the permitted range. Separate and label the affected vaccines, restore correct storage and document the excursion. Keep them unavailable for administration until a product-specific viability decision is made.
Common pitfall: Returning vaccines to the correct temperature does not restore lost potency. Conversely, discarding all affected stock immediately can precede an informed stability assessment.
12.How are most interrupted vaccine series resumed?
For most vaccine series, a prolonged interval between doses does not require restarting the series or adding extra doses. Earlier valid doses retain their contribution to immune priming, although protection can remain incomplete during the delay. Resume using the appropriate product schedule and minimum intervals. Distinguish a late dose from an invalid early dose, and recognise that specific vaccines or regimens can have exceptions requiring their own guidance.
Apply it
An adult presents years after valid initial hepatitis vaccination doses. Reconstruct the documented series and administer the remaining indicated dose or doses under the applicable schedule. Do not automatically restart because the original target dates were missed.
Common pitfall: The usual no-restart principle does not validate a dose given before a minimum interval or replace product-specific instructions for schedules with special requirements.
13.Why does an early infant MMR dose not complete routine protection?
Infants aged 6–11 months travelling internationally can receive an early MMR dose because exposure risk can justify protection before the routine schedule begins. Maternal antibodies and age-related immune responses can reduce the reliability of that early dose. It therefore does not count toward the routine two-dose series. After the first birthday, administer two appropriately spaced doses according to the applicable schedule, even if the infant received travel-related MMR earlier.
Apply it
An eight-month-old receives MMR before an international family visit. Explain that this provides an early protection opportunity but does not finish routine immunisation. Plan two valid doses after the first birthday using the recommended minimum spacing.
Common pitfall: Counting a dose given before 12 months as a routine series dose can leave the child with inadequate documented protection after infancy.
CDC Yellow Book: Travel Vaccine Recommendations for Infants and Children
14.Which itinerary features increase Japanese encephalitis vaccine benefit?
CDC recommends Japanese encephalitis vaccination for people moving to endemic countries, longer-term travellers such as those staying at least one month in endemic areas, and frequent travellers to endemic areas. Consider vaccination for shorter trips with increased exposure because of season, rural location, outdoor activities or unscreened accommodation, and when exposure details are uncertain. Duration is one factor, not an absolute safety boundary. Short urban trips with little relevant exposure generally do not warrant vaccination.
Apply it
A traveller spending six weeks working near rice fields in an endemic area has a recommended indication. A ten-day rural assignment involving evening outdoor work during transmission season warrants consideration despite lasting less than one month; a short urban conference presents a different risk profile.
Common pitfall: Interpreting one month as a minimum duration for any vaccine consideration misses shorter high-exposure trips. Country name alone also fails to capture season, rural activities and accommodation.
15.When can non-live vaccines be given with other vaccines?
Non-live vaccines generally do not require a minimum interval before or after other vaccines. They do not rely on replication of a live vaccine organism, so the usual interference rule for separate-day live-virus vaccines does not apply. This permits efficient pretravel catch-up and simultaneous administration at different anatomical sites. The doses within each individual vaccine series must still meet their own minimum ages and intervals to be considered valid.
Apply it
A traveller received MMR last week and now needs an indicated inactivated hepatitis vaccine. The non-live vaccine can generally be administered today. Check its own series timing rather than delaying it solely because MMR was recently given.
Common pitfall: Freedom to coadminister different vaccines does not permit shortening the minimum interval between doses of the same series or ignoring product-specific administration instructions.
CDC Yellow Book: Vaccination and Immunoprophylaxis—General Principles
16.Why is first-time yellow fever vaccination after age 60 a precaution?
Age 60 years or older is a precaution for yellow fever vaccination because serious vaccine-associated adverse events occur more frequently in older recipients. A precaution calls for an individual risk-benefit assessment rather than automatic vaccination or automatic refusal. Consider whether this is a first dose, actual transmission risk, trip duration, activities and possible itinerary changes. A certificate requirement without meaningful exposure can create a different balance from substantial unavoidable infection risk.
Apply it
A 68-year-old requests a first yellow fever dose for an itinerary with a documentation requirement but no meaningful exposure. Compare vaccine risk with itinerary changes and waiver options before proceeding; age alone does not settle every travel scenario.
Common pitfall: A precaution is not identical to an absolute contraindication. Equally, treating every certificate request as a sufficient indication bypasses the required risk-benefit assessment.
17.What distinguishes yellow fever vaccine-associated viscerotropic disease?
Yellow fever vaccine-associated viscerotropic disease is a rare severe adverse event in which vaccine virus proliferates and causes systemic injury resembling wild-type yellow fever. Multiorgan dysfunction distinguishes it from expected mild post-vaccination symptoms. The mechanism explains why recipient factors affecting vaccine-virus control matter during screening. A seriously ill recent vaccine recipient requires urgent assessment; temporal association alone cannot establish the diagnosis or exclude an unrelated infection acquired during travel.
Apply it
A recently vaccinated traveller develops progressive systemic illness with organ dysfunction rather than mild transient soreness or fever. Arrange urgent evaluation and ensure the vaccination date is communicated so clinicians can consider a serious vaccine-associated event.
Common pitfall: Do not label severe progressive illness as an ordinary vaccine reaction. Conversely, common mild symptoms after vaccination do not themselves establish viscerotropic disease.
18.How do vaccine indications differ from entry requirements?
A clinical vaccination recommendation aims to reduce the traveller's risk of disease. An entry requirement is a legal condition imposed by a destination, sometimes influenced by the route of arrival or transit history. A traveller can need protection despite facing no certificate requirement, or face a certificate requirement despite little direct exposure. Evaluate both questions separately, including vaccine safety, and then produce the correct documentation for the actual itinerary.
Apply it
A traveller asks whether yellow fever vaccine is unnecessary because the destination does not request a certificate. Review the specific exposure area: absence of an entry requirement does not exclude a clinical indication for vaccination.
Common pitfall: A border rule is not a complete disease-risk assessment. Following only the paperwork requirement can miss protection needs or lead to inappropriate vaccination.
CDC Yellow Book: Yellow Fever · CDC Yellow Book: The Pre-Travel Consultation
Pretravel Assessment/Consultation35%
19.Which itinerary details change a pretravel recommendation?
Risk assessment connects the traveller's susceptibility with the exposures likely on the actual trip. Establish exact destinations, dates, duration, rural or urban settings, activities, accommodation and access to care. Then integrate age, medical conditions, medicines, allergies and vaccination history. These details determine whether a hazard is plausible and which preventive measures are suitable. A country-level recommendation is a starting framework, not a substitute for identifying the traveller's particular exposure pattern.
Apply it
A business traveller adds a rural home stay and overnight outdoor work to an urban itinerary. Reassess mosquito exposure, malaria prevention and access to care instead of simply retaining advice prepared for the original hotel-based conference.
Common pitfall: A familiar destination does not imply a familiar risk profile. Changes in season, accommodation or activities can materially alter the same traveller's prevention needs.
20.Why is quantitative G6PD testing required before certain antimalarials?
Primaquine and tafenoquine can cause haemolysis in people with glucose-6-phosphate dehydrogenase deficiency. A documented quantitative G6PD result is required before prescribing either drug, with eligibility interpreted against the drug-specific criteria. Quantitative testing measures enzyme activity and can reveal intermediate activity that a simple qualitative screen may miss. Do not infer safety from absence of anaemia, ancestry, or a previous uneventful illness. Pregnancy and breastfeeding introduce additional restrictions beyond the traveller's own result.
Apply it
A traveller requests tafenoquine and reports that a previous screening test was 'normal', but no quantitative result is available. Obtain appropriate quantitative testing before prescribing, or choose another suitable prevention option for the itinerary.
Common pitfall: A normal blood count does not establish normal G6PD activity. A qualitative result also cannot automatically substitute for the required quantitative safety assessment.
21.Why is avoiding malaria exposure especially important during pregnancy?
Malaria during pregnancy increases the risk of severe maternal illness and adverse fetal outcomes. No preventive regimen provides complete protection, and pregnancy limits medication choices. Avoiding or postponing travel to areas with malaria transmission offers the greatest prevention. If travel is unavoidable, select pregnancy-compatible prophylaxis for the destination and reinforce mosquito precautions. The decision depends on local resistance as well as maternal factors; a drug suitable for one destination may be unsuitable elsewhere.
Apply it
A pregnant traveller can postpone a recreational trip to a malaria-transmission area. Explain why postponement provides stronger protection than choosing tablets alone. If the trip cannot change, assess destination-specific prophylaxis and practical mosquito avoidance together.
Common pitfall: A prescription does not eliminate pregnancy-related malaria risk. A drug's general effectiveness against malaria does not establish its suitability during pregnancy or at that destination.
22.How does functional severity guide travellers' diarrhoea treatment?
Travellers' diarrhoea severity is assessed by its effect on activities, rather than stool count alone. Mild illness is tolerable and does not interfere with planned activities; antibiotics are generally not recommended. Moderate illness is distressing or interferes with activities, while severe illness is incapacitating or prevents activities, and all dysentery is considered severe. This approach links treatment benefit to clinical burden while limiting unnecessary antibiotic exposure and its adverse effects and resistance consequences.
Apply it
A traveller has several loose stools but feels well and continues sightseeing comfortably. Classify the illness as mild, emphasise fluid replacement and discuss suitable symptom relief rather than treating the number of stools alone as an antibiotic indication.
Common pitfall: Frequent stools do not automatically mean severe disease. Blood in stool, however, changes classification and management even when the traveller initially reports limited functional impairment.
23.Which water treatment reliably addresses Cryptosporidium?
Cryptosporidium oocysts resist the chlorine and iodine concentrations and contact times practical for routine traveller disinfection. Boiling or an appropriately rated filter provides a more reliable barrier for this organism. Treatment choice must account for all likely contaminants, because a filter effective against protozoa may not remove viruses. Combining suitable filtration with another disinfection method can address different hazards. Check the actual device specification rather than assuming that every portable filter provides equivalent protection.
Apply it
A camper must use lake water where protozoal contamination is possible. Choose boiling or an appropriately specified filtration approach, adding treatment for other hazards as needed, instead of relying solely on ordinary chlorine tablets.
Common pitfall: Water that looks clear can still contain oocysts. Increasing confidence in a familiar chemical treatment does not overcome its practical limitations against Cryptosporidium.
24.How should permethrin and skin repellents be combined?
Permethrin is used to treat clothing, bed nets and equipment, where it provides an additional barrier against arthropods. It should not be applied directly to skin as a personal repellent. An appropriate skin repellent protects exposed areas, while clothing coverage, screens and nets reduce opportunities for bites. Follow product instructions for application, drying and retreatment. Different vectors bite at different times, so protection should match the itinerary's hazards rather than a dusk-only assumption.
Apply it
A field worker plans to spray permethrin onto bare arms before evening work. Redirect it to approved clothing and equipment uses, and select an appropriate repellent for exposed skin alongside protective clothing and sleeping arrangements.
Common pitfall: A treated shirt does not protect every exposed skin surface. Permethrin's usefulness on fabric does not make it an appropriate direct skin application.
25.When is loperamide alone inappropriate for diarrhoea?
Loperamide reduces intestinal motility and can relieve symptoms, but it does not treat an invasive infection. It should not be used as sole treatment for bloody diarrhoea or diarrhoea accompanied by fever. These findings raise concern for inflammatory disease and require a different treatment and assessment plan. Rehydration remains essential, and severe illness, dehydration or systemic deterioration warrants prompt care. Selected adjunctive use with appropriate antimicrobial treatment is different from antimotility monotherapy.
Apply it
A traveller develops blood in the stool and fever and plans to take only loperamide before a long bus journey. Advise against this approach and arrange assessment and appropriate treatment rather than merely suppressing stool frequency.
Common pitfall: Temporary symptom control can create false reassurance while invasive disease continues. The restriction concerns monotherapy; it should not be misread as banning every clinician-directed adjunctive use.
26.Why does previous endemic residence not ensure malaria protection?
Repeated exposure in endemic settings can produce partial malaria immunity, but that protection is incomplete and wanes after a person leaves transmission areas. Travellers visiting friends and relatives should therefore not assume that childhood residence or previous infections make prophylaxis unnecessary. Longer stays, local accommodation and reduced perception of risk can increase exposure. Assess the current itinerary and traveller as carefully as for other visitors, including children born outside endemic regions.
Apply it
A person returning to their childhood village after ten years abroad declines prophylaxis because they 'grew up with malaria'. Explain waning partial immunity and plan destination-appropriate prevention for both the adult and accompanying locally born children.
Common pitfall: Familiarity with a place is not biological protection. A traveller's memories of mild childhood episodes cannot predict the severity of a future infection.
27.How should malaria prevention be planned for a breastfed infant?
Antimalarial concentrations transferred through breast milk do not provide adequate malaria prophylaxis for the infant. Assess the infant separately and prescribe an appropriate weight-based regimen when exposure warrants it. Also assess whether the mother's chosen medicine is compatible with breastfeeding and the infant's characteristics. Mosquito avoidance must protect both travellers. For drugs associated with G6PD-related haemolysis, maternal and infant testing requirements can be relevant; the mother's result alone does not establish infant safety.
Apply it
A breastfeeding parent taking malaria prophylaxis asks whether their infant is automatically protected. Explain the inadequate drug transfer and arrange an infant-specific risk assessment, suitable prophylaxis if indicated, and practical bite prevention for feeding and sleeping.
Common pitfall: Detectable medicine in breast milk is not equivalent to a protective infant dose. Maternal drug suitability and infant prophylactic adequacy are separate decisions.
28.What minimum intervals are recommended between diving and flying?
Reduced cabin pressure after diving can promote inert-gas bubble formation or expansion and increase decompression-sickness risk. For asymptomatic divers, CDC recommends minimum preflight surface intervals of at least 12 hours after a single no-decompression dive, at least 18 hours after multiple dives or multiple days of diving, and 24–48 hours after dives requiring decompression stops. These intervals reduce rather than eliminate risk. Symptoms require medical assessment; completing an interval does not establish fitness to fly.
Apply it
A traveller completes several no-decompression dives over two days and plans to fly six hours later. Rearrange the flight to allow at least 18 hours, explaining that residual risk remains. If a dive required decompression stops, apply the recommended 24–48-hour interval instead.
Common pitfall: The single-dive interval should not be applied to repetitive or decompression-stop diving. A symptomatic diver needs assessment even when the recommended interval has elapsed.
CDC Yellow Book: Scuba Diving—Decompression Illness and Other Dive-Related Injuries
29.How can travellers prevent interruptions to essential medicines?
Medication continuity requires planning for routine dosing, delays, loss, storage and access abroad. Carry an adequate additional supply in correctly labelled containers, with essential medicines accessible during transit and supporting clinical documentation when appropriate. Review destination restrictions and whether temperature-sensitive medicines can remain within their required conditions. A medication list should identify generic names and indications because brands differ internationally. Substituting unfamiliar products abroad can introduce formulation, quality and interaction problems.
Apply it
A traveller using insulin has a tight connection and an itinerary with limited pharmacy access. Plan accessible supplies, backup quantities, suitable storage and a clear medication record before departure instead of relying on replacement at the destination.
Common pitfall: An electronic prescription at home may not secure an equivalent product abroad. Packing the entire supply in checked luggage creates an avoidable interruption risk.
30.What remains useful at a last-minute consultation?
A short interval before departure does not remove the value of pretravel care. Prioritise major itinerary-specific hazards, indicated vaccines that can still provide benefit, suitable accelerated schedules where authorised, malaria prevention and practical self-care advice. Explain when protection will remain incomplete and arrange subsequent doses. Some interventions require lead time or cannot meet an entry deadline, but others can still reduce risk. Separate achievable clinical benefit from documentation that will not yet be valid.
Apply it
A traveller leaves in three days without prior advice. Address malaria risk, food and water safety, bite prevention and indicated vaccination now, while explaining incomplete protection and any certificate timing that makes the original itinerary impractical.
Common pitfall: Saying it is 'too late for everything' loses useful prevention opportunities. Conversely, administering a vaccine today does not imply immediate immunity or immediate certificate validity.
31.Which food choices reduce enteric exposure?
Food safety depends on preparation, temperature, handling and water quality rather than a restaurant's appearance. Thoroughly cooked food served hot and fruit peeled personally generally offer safer choices than raw produce or food held at uncertain temperatures. Contamination can occur after cooking, so preparation and serving conditions both matter. These precautions reduce opportunities for exposure but do not guarantee prevention; travellers should also understand hydration, symptom management and when diarrhoeal illness requires care.
Apply it
At a roadside stop, a traveller can choose freshly cooked food served steaming hot or a room-temperature salad rinsed with uncertain water. Recommend the hot food and personally peeled fruit while explaining that no meal choice eliminates all risk.
Common pitfall: An expensive venue does not establish safe water or handling. Cooked food can become hazardous again if contaminated or kept at unsafe temperatures.
32.Why must oral rehydration salts use the specified water volume?
Oral rehydration solution uses coupled intestinal absorption of glucose and sodium to promote water uptake despite ongoing diarrhoea. Its effectiveness and safety depend on the intended balance of water, salts and glucose. Dissolve a packaged formulation in exactly the stated volume of safe water. Excess powder or too little water produces an overly concentrated solution; excessive dilution reduces electrolyte replacement. Severe dehydration, inability to drink or progressive illness requires medical evaluation.
Apply it
A traveller has one oral rehydration packet intended for a litre but only a half-litre bottle. Obtain the full specified volume of safe water instead of emptying the entire packet into the smaller bottle.
Common pitfall: A stronger solution is not more effective rehydration. Very sugary drinks also do not reproduce the balanced electrolyte and glucose composition of oral rehydration solution.
33.Which psychiatric histories make mefloquine unsuitable?
Mefloquine prophylaxis is contraindicated with active or recent depression, generalised anxiety disorder, psychosis, schizophrenia, other major psychiatric disorders or seizures. It should also be avoided in people with a previous history of depression. Allergy to mefloquine or related compounds such as quinine and quinidine is another contraindication. These distinctions make a specific mental-health and neurological history essential. Convenience of weekly administration does not outweigh a relevant contraindication.
Apply it
A traveller prefers weekly malaria prophylaxis but was recently treated for depression. Exclude mefloquine and select another destination-appropriate option after reviewing renal function, pregnancy status, interactions and other relevant factors rather than prioritising the requested dosing frequency.
Common pitfall: Stable mood today does not erase recent depression. Asking only about current symptoms misses histories that materially change mefloquine's suitability for prophylaxis.
CDC: Choosing a Drug to Prevent Malaria · CDC Yellow Book: Malaria
34.When does renal impairment exclude atovaquone-proguanil prophylaxis?
Atovaquone-proguanil is contraindicated for malaria prophylaxis when creatinine clearance is below 30 mL/min. A general statement that kidney disease is 'stable' does not establish suitability; the actual renal-function assessment matters. Select an alternative that is effective at the destination and compatible with the traveller's other conditions. This prophylaxis threshold should be applied in its stated context rather than extrapolated casually to every antimalarial drug or all treatment decisions.
Apply it
A traveller's documented creatinine clearance is 24 mL/min, and atovaquone-proguanil is proposed for a malaria-risk itinerary. Choose another appropriate prophylactic strategy rather than assuming that a standard course is safe because the trip is brief.
Common pitfall: Reducing the prophylactic dose without an established regimen is not an adequate response to this contraindication. Renal suitability must be checked before prescribing.
35.Why combine malaria prophylaxis with mosquito precautions?
Chemoprophylaxis reduces malaria risk but does not provide complete protection. Missed doses, incorrect timing, vomiting, resistance and residual drug limitations can undermine prevention. Mosquito avoidance reduces infectious bites and also helps prevent vector-borne diseases unaffected by malaria tablets. Use an itinerary-appropriate regimen together with suitable repellents, clothing, nets and screened accommodation. Travellers should still seek urgent assessment for fever after malaria exposure, even when they report full adherence.
Apply it
A traveller taking prophylaxis plans to skip bed nets because the medicine 'covers malaria'. Explain the remaining infection risk and additional mosquito-borne hazards, then build a practical plan for sleeping protection and repellent use throughout the trip.
Common pitfall: Neither good adherence nor absence of remembered bites excludes malaria. Prevention history should inform assessment without dismissing compatible febrile illness after exposure.
36.How does cloudy water limit ultraviolet disinfection?
Ultraviolet treatment inactivates susceptible microorganisms only when adequate light reaches them. Suspended particles in cloudy water can shield organisms and reduce reliable disinfection. Follow the device's requirements for water clarity, volume, exposure time and power. Clarification or appropriate filtration may be necessary before UV treatment. The method also depends on functioning equipment, so remote travellers need a backup approach rather than assuming a working battery or a clear-looking endpoint proves effective treatment.
Apply it
A hiker's only water source is visibly turbid, and they have a handheld UV device. Clarify or filter the water as required before UV treatment, or use a reliable alternative such as boiling.
Common pitfall: Completing the device's timer does not overcome organism shielding in turbid water. UV treatment also does not remove suspended material or chemical contaminants.
37.Why is prolonged iodine water treatment unsuitable in pregnancy?
Repeated iodine exposure from water treatment can affect thyroid function, including the developing fetal thyroid. Pregnant travellers should therefore use safer suitable alternatives rather than relying on prolonged iodine-treated drinking water. People with thyroid disease or iodine-related contraindications also need particular caution. Choose a method that addresses the likely organisms and practical setting, such as boiling or an appropriate combined treatment approach. Iodine's limitations against Cryptosporidium provide an additional reason to assess alternatives.
Apply it
A pregnant traveller plans several weeks of trekking with iodine tablets as the sole drinking-water method. Replace this plan with a suitable alternative and verify that it addresses both the local microbial hazards and available field conditions.
Common pitfall: A product sold for travel is not automatically suitable for every traveller. Iodine's usefulness in some circumstances does not justify prolonged exposure during pregnancy.
38.When should unstable chronic disease change travel plans?
Fitness to travel depends on clinical stability, physiological demands, available support and access to appropriate care. Recent deterioration or poorly controlled disease can make postponement and stabilisation safer than adding preventive medicines. Consider air travel, exertion, altitude, heat and interruptions to treatment in relation to the individual's condition. A diagnosis alone does not determine fitness: two people with the same disease can have very different reserve, treatment needs and capacity to tolerate complications.
Apply it
A traveller with worsening breathlessness and a recent deterioration in chronic cardiopulmonary disease plans a remote high-altitude trip. Arrange assessment and stabilisation and reconsider timing rather than focusing the consultation exclusively on vaccines and a travel medicine kit.
Common pitfall: A routine prescription list does not establish clinical stability. Clearance for one low-demand itinerary should not be assumed to cover a remote or strenuous trip.
39.How should changing destination hazards alter counselling?
Destination assessment combines established geographic hazards with changing conditions such as outbreaks, seasonality, disrupted services and evolving resistance. Reassess the actual route near departure, especially when the itinerary changes. Translate new information into specific actions: altered vaccination advice, different prophylaxis, exposure restrictions or a revised plan for obtaining care. The existence of an alert does not mean every traveller has equal risk; its location, transmission route and affected activities must match the proposed exposure.
Apply it
A traveller's usual destination now has an outbreak affecting the rural district where they will volunteer. Revisit the relevant exposure routes and preventive options, including whether the assignment or accommodation should change before departure.
Common pitfall: Advice from a previous trip can become outdated. Conversely, applying a broad alert without checking geography and activities can overstate risk for an unaffected itinerary.
Diseases Contracted During Travel12%
40.How is schistosomiasis acquired from freshwater?
Schistosomiasis is acquired when cercariae released by infected freshwater snails penetrate human skin. Drinking the water is not required. Swimming, wading and other skin contact with freshwater in transmission areas can therefore cause infection. The risk is geographically specific and cannot be judged by whether water looks clean. Prevention centres on avoiding relevant freshwater exposure; advice aimed only at safe drinking water does not address this route of acquisition.
Apply it
A traveller wades knee-deep in an endemic lake but swallows no water. Record this as a relevant schistosomiasis exposure and explain the skin-penetration mechanism rather than dismissing the episode because drinking water came from sealed bottles.
Common pitfall: Avoiding ingestion does not prevent skin penetration. Clear water and a brief recreational exposure are not reliable evidence that freshwater contact was safe.
41.Why can dengue worsen as the fever resolves?
Dengue can enter a critical phase around defervescence, when increased vascular permeability can produce plasma leakage and circulatory compromise. A falling temperature therefore does not necessarily indicate recovery. Warning signs include severe abdominal pain, persistent vomiting, bleeding, lethargy or other evidence of deterioration. Recognition depends on the trajectory of illness and clinical assessment rather than fever alone. Travellers should receive clear instructions to seek prompt care if these features emerge as fever subsides.
Apply it
A traveller with suspected dengue becomes afebrile but develops persistent vomiting and marked abdominal pain. Treat these as warning signs requiring urgent reassessment rather than interpreting the normal temperature as permission to resume travel.
Common pitfall: Using fever resolution as the sole recovery marker can miss the period of greatest danger. Warning signs matter even before obvious shock develops.
42.Which environmental exposures suggest leptospirosis?
Leptospira organisms are shed in infected animal urine and can contaminate freshwater, mud and wet soil. Infection occurs through skin abrasions or mucous membranes, and prolonged immersion can increase susceptibility. Floodwater exposure, adventure races and freshwater activities can therefore be relevant even without an animal bite or deliberate ingestion. Connect a febrile illness to the exposure history, including timing and portals of entry, rather than restricting consideration to direct animal contact.
Apply it
After a muddy endurance race following heavy rain, a traveller develops fever and reports several leg abrasions. Recognise contaminated water and damaged skin as a plausible acquisition pathway, even though the traveller never handled an animal.
Common pitfall: Requiring a remembered animal bite misses an important environmental route. Waterproof footwear can reduce some exposure without guaranteeing that mucosal or skin contact never occurred.
43.What protection does typhoid vaccination leave incomplete?
Typhoid vaccines reduce the risk of disease caused by Salmonella Typhi but do not provide complete protection and do not reliably prevent paratyphoid fever. Food and water precautions remain necessary after vaccination. A vaccinated traveller with compatible sustained fever can still have enteric fever, so vaccination history must not close the diagnostic assessment. Distinguish the organism-specific vaccine target from the broader group of illnesses transmitted through contaminated food and water.
Apply it
A vaccinated traveller develops prolonged fever after eating with local households in an enteric-fever-risk area. Retain typhoid and paratyphoid in the assessment rather than ruling out enteric fever because a pretravel vaccination was documented.
Common pitfall: A vaccine against one enteric pathogen does not prevent every foodborne infection. Incomplete efficacy also means correct vaccination cannot exclude the target disease.
44.Why can vivax and ovale malaria relapse?
Plasmodium vivax and Plasmodium ovale can form dormant liver stages called hypnozoites. These can reactivate after blood-stage infection has been cleared, producing relapse without a new mosquito exposure. Management therefore distinguishes treatment of the acute blood-stage illness from eradication of dormant liver infection. Drugs used for antirelapse treatment require attention to G6PD status and other contraindications. This mechanism differs from recurrence caused by inadequately cleared blood-stage parasites or a new infection.
Apply it
A traveller has another confirmed P. vivax episode months after successful blood-stage treatment and no further travel. Consider hypnozoite activation and review whether appropriate antirelapse treatment was given and whether G6PD-related safety requirements were addressed.
Common pitfall: A later episode does not necessarily prove poor adherence or reinfection. Clearing circulating parasites alone does not establish eradication of dormant liver stages.
45.Which saliva contacts can transmit rabies?
Rabies virus can be transmitted when infected saliva enters broken skin or contacts mucous membranes. Bites are a major route, but a lick onto an open wound or saliva exposure to an eye can also be relevant. Contact with intact skin is different. Prompt cleansing and expert exposure assessment are essential because disease is almost invariably fatal once symptoms develop. Evaluate the animal, geography and contact details rather than using the presence of a bite alone.
Apply it
A dog licks a traveller's fresh abrasion in a rabies-risk setting. Recommend immediate cleansing and urgent exposure assessment, even though there was no bite. Document the animal and circumstances to support appropriate post-exposure decisions.
Common pitfall: No bite does not mean no exposure. Conversely, saliva on fully intact skin should not automatically be equated with inoculation through a wound.
46.Why should aspirin and NSAIDs be avoided in suspected dengue?
Dengue can cause thrombocytopenia, haemostatic abnormalities and clinically important bleeding. Aspirin and other nonsteroidal anti-inflammatory drugs can worsen bleeding risk and should be avoided in suspected dengue. Appropriate supportive care includes hydration, suitable fever relief and monitoring for warning signs. Medication choice must accompany assessment of the illness phase and severity; symptom relief does not correct plasma leakage or shock. A traveller should not interpret reduced pain or fever as proof of uncomplicated recovery.
Apply it
A febrile traveller with suspected dengue asks to continue ibuprofen for myalgia. Recommend avoiding it because of bleeding risk and arrange appropriate supportive advice and reassessment instructions, especially for warning signs around defervescence.
Common pitfall: An over-the-counter medicine can still increase disease-specific harm. Choosing a safer antipyretic does not replace monitoring for bleeding, dehydration or evolving severe dengue.
Other Clinical Conditions Associated with Travel10%
47.When do altitude symptoms indicate cerebral illness?
Ataxia or altered mental status after ascent suggests high-altitude cerebral oedema, a medical emergency rather than uncomplicated acute mountain sickness. Stop further ascent and arrange urgent descent with assistance; supplemental oxygen and dexamethasone are useful when available. Do not leave an affected person to descend alone. Waiting for spontaneous improvement at the same altitude can be dangerous. The neurological findings are decisive because headache alone is less specific and can occur in milder altitude illness.
Apply it
After rapid ascent, a trekker with headache becomes confused and cannot walk heel-to-toe. Begin emergency descent planning, provide available oxygen and appropriate emergency treatment, and ensure companions assist rather than allowing the trekker to rest alone.
Common pitfall: Attributing unsteady walking to fatigue can delay lifesaving action. Symptom medication does not make continued ascent appropriate when cerebral altitude illness is suspected.
48.How does prolonged travel promote venous thrombosis?
Prolonged seated immobility reduces venous flow in the legs and contributes to venous stasis, a component of thrombosis risk. Long-distance travel risk is influenced by duration and personal factors such as previous venous thromboembolism, recent surgery and other prothrombotic conditions. Regular movement and calf exercises address stasis. Travellers at substantially increased risk may need individually selected additional measures. Routine medication for every traveller is not justified simply because a journey is long.
Apply it
A traveller plans a long flight and expects to remain seated throughout. Recommend periodic walking when safe and calf-muscle exercises while seated, then assess personal risk factors before deciding whether measures beyond mobility are appropriate.
Common pitfall: Hydration alone does not directly resolve prolonged venous stasis. A general long-flight recommendation should not be substituted for an individual assessment after recent thrombosis or surgery.
CDC Yellow Book: Deep Vein Thrombosis and Pulmonary Embolism
49.Why can looking at the horizon reduce motion sickness?
Motion sickness arises from conflicting sensory information about movement, especially disagreement between vestibular and visual inputs. Reading below deck can create a mismatch between perceived visual stability and sensed motion. Looking at the horizon, minimising head movement and choosing a position with less motion can reduce the conflict. Behavioural measures are useful preventive tools, while medication choices require attention to sedation and other adverse effects. Susceptibility varies and symptoms do not necessarily imply an inner-ear disorder.
Apply it
A passenger becomes nauseated while reading in a moving boat cabin. Suggest stopping the reading, moving to a suitable position with a view of the horizon and limiting head movement before relying solely on additional medication.
Common pitfall: Concentrating on a nearby stationary page can worsen the sensory mismatch. Sedating medication can also create safety problems for someone expected to drive or operate equipment.
50.Which findings distinguish heat stroke from heat exhaustion?
Heat stroke is characterised by dangerous hyperthermia with central nervous system dysfunction, such as confusion, ataxia, seizures or coma. It requires emergency cooling and urgent medical care. Heat exhaustion can cause weakness, dizziness and heavy sweating but does not account for significant neurological dysfunction in the same way. Sweating does not exclude heat stroke, particularly during exertion. Begin cooling promptly rather than waiting for an ideal temperature measurement or complete diagnostic confirmation.
Apply it
During a hot-weather race, a runner becomes confused and staggers despite continuing to sweat. Treat the presentation as possible heat stroke, initiate rapid cooling and activate emergency care rather than offering fluids and observing alone.
Common pitfall: Dry skin is not required for heat stroke. Waiting for sweating to stop or for a particular thermometer reading can delay essential emergency cooling.
51.How does pressure change cause barotrauma?
Barotrauma occurs when pressure in an air-containing body space cannot equalise with changing surrounding pressure. During flight, obstruction of the Eustachian tube or sinus drainage can create painful pressure differences, especially during descent. Swallowing, yawning and appropriate equalisation techniques can help when pathways remain functional. Significant congestion or active ear or sinus disease can increase risk and may justify postponement. The mechanism is pressure disequilibrium rather than an infection caused by cabin air itself.
Apply it
A traveller with severe nasal congestion develops sharp ear pain during aircraft descent. Recognise impaired middle-ear pressure equalisation as the likely mechanism and assess symptom severity rather than assuming the pain proves a new bacterial infection.
Common pitfall: Antibiotics do not correct a pressure gradient. Forceful attempts at equalisation are not a substitute for assessing severe pain, hearing changes or persistent symptoms.
52.How does worsening hypothermia affect judgement and movement?
Progressive cooling impairs neuromuscular function and cognition, producing clumsiness, confusion and eventually reduced consciousness or coma. The affected person may become unable to recognise danger or help with rescue. Shivering can diminish as hypothermia becomes severe, so its absence is not reassuring. Stop ongoing heat loss, provide shelter and appropriate insulation, and arrange urgent care for significant impairment. Wet and windy conditions can produce dangerous cooling even without extreme subzero temperatures.
Apply it
A wet hiker becomes confused and repeatedly drops equipment after prolonged cold exposure. Treat the behavioural and coordination changes as possible hypothermia, remove the person from exposure and organise assistance rather than asking them to continue independently.
Common pitfall: A person who stops shivering may be deteriorating rather than warming. Confusion also makes self-reported comfort or willingness to continue an unreliable safety assessment.
Post-Travel Assessment8%
53.How should suspected malaria be investigated after a negative smear?
Malaria requires urgent consideration in a febrile traveller returning from a transmission area. Obtain prompt thick and thin blood smears through a service capable of timely interpretation. A single negative examination does not exclude low-density parasitaemia, especially early in illness. If suspicion remains, repeat smears every 12–24 hours until three sets are negative. Prevention history cannot exclude infection, and an unstable patient needs emergency management while diagnostic assessment proceeds.
Apply it
A febrile returnee from a malaria area has one negative smear but no convincing alternative diagnosis. Arrange repeat examinations at the recommended intervals and maintain urgent clinical review rather than closing the malaria assessment after the first result.
Common pitfall: Reported adherence to prophylaxis does not eliminate malaria. Sending testing to a laboratory that cannot provide timely results can also create a dangerous diagnostic delay.
54.Which persistent diarrhoea pattern suggests giardiasis?
Giardia is an important cause of persistent post-travel diarrhoea, particularly when symptoms include flatulence, bloating and fatty stools suggesting malabsorption. This pattern differs from a short, self-limited watery episode or prominent inflammatory dysentery. Stool antigen testing or molecular testing can establish the diagnosis; microscopy may also be used according to laboratory practice. Persistent symptoms require aetiological assessment rather than repeated empirical antibacterial courses that may not address a protozoal cause.
Apply it
A traveller has three weeks of bloating, excess gas and greasy stools after camping. Request appropriate Giardia testing and assess hydration and nutrition rather than assuming that another routine antibacterial course will resolve the prolonged illness.
Common pitfall: Duration alone does not identify Giardia, but malabsorptive features strengthen the clue. A generic bacterial stool culture does not adequately test for every protozoal cause.
55.Why can eosinophilia precede positive stool parasite tests?
Eosinophilia can accompany tissue migration by helminths before mature parasites produce eggs detectable in stool. A negative stool examination therefore does not exclude an early helminth infection. Interpret the absolute eosinophil count alongside timing, itinerary, freshwater contact, soil exposure and other potential causes, including medicines and allergic disease. Not all parasites cause eosinophilia, and established luminal infection can produce a different response from tissue invasion. Select additional testing according to the suspected organism.
Apply it
A returnee has eosinophilia after relevant environmental exposure, but an early stool examination is negative. Review the exposure-to-testing interval and consider organism-specific testing rather than concluding that all parasitic causes have been excluded.
Common pitfall: Eosinophilia is neither a universal parasite marker nor proof of parasitic infection. Repeated undirected stool tests can miss the relevant tissue phase or organism.
CDC Yellow Book: Post-Travel Parasitic Disease Including Evaluation of Eosinophilia
56.When should an asymptomatic returnee be screened?
Screening should follow specific exposures, travel duration and host factors. Consider Schistosoma serology after freshwater exposure in a schistosomiasis-endemic area, even when the traveller has no symptoms. Screening is most sensitive 8–10 weeks after exposure, allowing time for an antibody response to develop. Stool or urine examination has limited sensitivity in light infections because egg shedding can be sparse or inconsistent. Serology is particularly useful in previously uninfected travellers.
Apply it
A previously uninfected volunteer returns after swimming in freshwater in a schistosomiasis-transmission area. Consider Schistosoma antibody testing 8–10 weeks after the last freshwater exposure. If the consultation occurs two weeks after exposure, schedule testing for the later window rather than treating an early negative result as exclusion of infection. A negative stool or urine examination alone would also provide insufficient reassurance.
Common pitfall: Schistosoma antibodies can persist after previous infection and treatment, making a positive result difficult to interpret as evidence of a new or active infection. Establish previous infection and treatment history. Exposure-directed screening does not justify universal parasite or serology panels for every asymptomatic traveller.
CDC Yellow Book: Perspectives—Screening Asymptomatic Travelers
57.How should infection control shape returned-traveller triage?
Initial triage should assess illness severity and whether the presentation could expose staff or other patients to a transmissible infection. Use symptoms, itinerary, contacts and exposure history to institute appropriate precautions promptly, while stabilisation and diagnostic work continue. A final diagnosis is not required before starting indicated isolation measures. Communicate relevant travel and exposure information to the receiving team and involve infection-control or public-health expertise when a high-consequence infection is plausible.
Apply it
A returned traveller with fever, cough and a potentially contagious rash arrives in a crowded clinic. Begin appropriate separation and precautions while obtaining the travel and vaccination history, rather than completing the entire assessment in the shared waiting area.
Common pitfall: An unusual destination should not distract from ordinary transmissible infections. Waiting for confirmatory testing before instituting indicated precautions creates avoidable exposure for others.
Administrative and General Travel Medicine Issues5%
58.When does a yellow fever certificate become valid?
Under the amended International Health Regulations, a qualifying yellow fever vaccination certificate is valid for the lifetime of the vaccinated person. Initial certificate validity begins ten days after primary vaccination. The lifetime rule applies to qualifying existing certificates as well as newly issued ones, including certificates originally showing a ten-year expiry. Administrative certificate validity and a clinical decision about an additional dose are separate questions; a border certificate should not be treated as an assessment of every individual's immunity.
Apply it
A traveller presents a properly completed yellow fever certificate issued twelve years ago with an old ten-year expiry notation. Explain its lifetime validity under the amended rules rather than automatically requiring revaccination solely because that printed interval has passed.
Common pitfall: Lifetime validity does not remove the initial ten-day interval after primary vaccination. Nor does an administratively valid certificate answer every clinical question about additional vaccination.
WHO: Amendment to International Health Regulations Annex 7—Yellow Fever
59.Which insurance provisions address different travel losses?
Travel insurance for cancellation or disruption, travel health insurance for treatment costs, and medical evacuation insurance address different financial risks. One policy may combine them, but coverage should never be assumed from its title. Review exclusions, pre-existing condition rules, activity restrictions, payment arrangements and the destination to which evacuation can occur. Evacuation to a suitable facility is not necessarily repatriation to the traveller's home country. Match coverage to the itinerary and existing healthcare arrangements.
Apply it
A traveller with cancellation insurance assumes it will fund hospital care and transport home after a remote trekking injury. Review the medical and evacuation provisions explicitly, including trekking exclusions and the insurer's authority to select the receiving facility.
Common pitfall: A policy's purchase price or broad marketing name does not establish medical coverage. Evacuation benefits also need not promise a flight home on request.
CDC Yellow Book: Travel Insurance, Travel Health Insurance, and Medical Evacuation Insurance
60.What does a yellow fever medical waiver establish?
A medical waiver documents that vaccination is medically contraindicated or otherwise inappropriate under the applicable guidance. It does not confer immunity and does not guarantee acceptance by the destination's border authorities. Correct certificate documentation and a supporting letter can help communicate the medical reason, but the traveller must understand the possibility of refusal or other entry measures. When meaningful infection risk exists, postponement or rerouting can be safer than relying on documentation and bite precautions alone.
Apply it
A traveller with a genuine yellow fever vaccine contraindication must cross a border requiring certification. Prepare appropriate waiver documentation, explain uncertain border acceptance and reassess whether the route can change, especially if it includes actual transmission risk.
Common pitfall: A waiver resolves neither biological susceptibility nor every administrative obstacle. It should not be offered merely as a convenient substitute for an indicated, safe vaccination.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give the largest share of study time to Pretravel Assessment/Consultation: turn destinations, dates, activities and host factors into specific preventive decisions.
- Contrast vaccine contraindications, precautions, minimum intervals and incomplete protection; connect each rule to its biological or safety rationale.
- Build a malaria selection framework covering destination resistance, pregnancy, breastfeeding, renal function, psychiatric history and quantitative G6PD testing.
- Practise the transition from self-care to urgent assessment: dysentery, dengue warning signs, neurological altitude illness, heat stroke and fever after malaria exposure.
- Calculate attack risk, prevalence, person-time incidence, case fatality and absolute risk differences using clearly labelled denominators; compare disease risk within countries as well as between destinations.
- Keep clinical recommendations, legal entry requirements, vaccination documentation and insurance coverage conceptually separate.
- Use the complete ISTM outline to extend beyond these selected concepts into additional vaccines, infections, special populations, environmental hazards and clinic responsibilities.
A practical preparation plan
1. Map the full examination scope
Read the complete linked 2017 ISTM Body of Knowledge and mark each topic as secure, uncertain or unfamiliar. Use its approximate domain weights to distribute study time, while retaining coverage of every domain.
2. Build decision tables
Create compact comparisons for live-vaccine timing, yellow fever contraindications versus precautions, and malaria drug suitability. Record the decisive criterion and the most tempting unsafe alternative for each decision.
3. Work through complete itineraries
Practise contrasting an urban business trip, a rural VFR visit, pregnancy, an infant travelling with a breastfeeding parent, a remote assignment and diving followed by flight. Explain why each changed detail alters the plan.
4. Rehearse recognition and escalation
For fever, persistent diarrhoea, eosinophilia, neurological symptoms and heat illness, state the discriminating cue, immediate action and diagnostic limitation. Include repeat malaria testing and early infection-control decisions.
5. Use the drills diagnostically
Complete the 20 questions before reading their explanations. For each error, identify whether the problem was an incorrect fact, missed cue, denominator error or unsafe generalisation; then explain why every alternative was less appropriate.
6. Expand and revisit
Use the flashcards for spaced recall, then return to uncovered official-outline topics and their authoritative references. Recheck changing destination hazards and relevant national guidance separately from the outline's revision date.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ISTM CTH® Program
- ISTM Body of Knowledge
- ISTM CTH® FAQs
- CDC Principles of Epidemiology: Morbidity Frequency Measures
- CDC Principles of Epidemiology: Mortality Frequency Measures
- CDC Field Epidemiology Manual: Analyzing and Interpreting Data
- CDC Yellow Book: Vaccination and Immunoprophylaxis—General Principles
- CDC: Timing and Spacing of Immunobiologics
- CDC Vaccine Storage and Handling Toolkit, July 2026
- CDC Yellow Book: Travel Vaccine Recommendations for Infants and Children
- CDC Yellow Book: Japanese Encephalitis
- CDC Yellow Book: Yellow Fever
- CDC Yellow Book: Rabies
- CDC Yellow Book: The Pre-Travel Consultation
- CDC Yellow Book: Malaria
- CDC: Choosing a Drug to Prevent Malaria
- CDC Yellow Book: Travelers’ Diarrhea
- CDC Yellow Book: Water Disinfection for Travelers
- CDC Yellow Book: Mosquitoes, Ticks, and Other Arthropods
- CDC Yellow Book: Visiting Friends and Relatives—VFR Travel
- CDC Yellow Book: Scuba Diving—Decompression Illness and Other Dive-Related Injuries
- CDC Yellow Book: Travelers with Chronic Illnesses
- CDC Yellow Book: Last-Minute Travelers
- CDC Yellow Book: Food and Water Precautions for Travelers
- CDC Yellow Book: Schistosomiasis
- CDC Yellow Book: Dengue
- CDC Yellow Book: Leptospirosis
- CDC Yellow Book: Typhoid and Paratyphoid Fever
- CDC: Treatment of Uncomplicated Malaria
- CDC Yellow Book: High-Altitude Travel and Altitude Illness
- CDC Yellow Book: Deep Vein Thrombosis and Pulmonary Embolism
- CDC Yellow Book: Motion Sickness
- CDC Yellow Book: Heat and Cold Illness in Travelers
- CDC Yellow Book: Air Travel
- CDC: Evaluation and Diagnosis of Malaria
- CDC Yellow Book: Post-Travel Diarrhea
- CDC Yellow Book: Post-Travel Parasitic Disease Including Evaluation of Eosinophilia
- CDC Yellow Book: Perspectives—Screening Asymptomatic Travelers
- CDC Yellow Book: Post-Travel Evaluation of the Ill Traveler
- WHO: Amendment to International Health Regulations Annex 7—Yellow Fever
- CDC Yellow Book: Travel Insurance, Travel Health Insurance, and Medical Evacuation Insurance
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.